A novel accelerated oxidative stability screening method for pharmaceutical solids

Journal of Pharmaceutical Sciences

Volumn 100, Issue 8, 2011, Pages 3529-3538

  Zhu, Donghua Alan ^a   Zhang, Geoff G Z ^a   George, Karen L S T ^a   Zhou, Deliang ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Accelerated oxidative stability; Crystal form; Ephedrine; Ephedrine hydrochloride.; Hydrate; Pharmaceutical; Salt; Solid; Urea hydrogen peroxide

Indexed keywords

EPHEDRINE; HYDROGEN PEROXIDE; PEROXIDE; UREA;

ACCELERATION; DECOMPOSITION; DRUG DEGRADATION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG OXIDATION; DRUG STABILITY; HUMIDITY; NOTE; OXIDATIVE STRESS; SCREENING; SOLID STATE; SPECTROPHOTOMETRY; VAPOR;

EID: 79958778213     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22580     Document Type: Article

References (20)

1. Crowley PP, Martini L. 2001. Drug-excipient interactions. Pharm Technol Eur 13(3):26-34.
2. Reid DL, Calvitt CJ, Zell MT, Miller KG, Kingsmill CA. 2004. Early prediction of pharmaceutical oxidation pathways by computational chemistry and forced degradation. Pharm Res 21(9):1708-1717.
3. Boccardi G, Deleuze C, Gachon M, Palmisano G, Vergnaud JP. 1992. Autoxidation of tetrazepam in tablets: Prediction of degradation impurities from the oxidative behavior in solution. J Pharm Sci 81(2):183-185.
4. Brussol C, Duane M, Carlier P, Kotzias D. 1999. Photo-induced OH reactions of naphthalene and its oxidation products on SiO(2). Environ Sci Pollut Res Int 6(3):138-140.
5. Buettner GR, Jurkiewicz BA. 1996. Catalytic metals, ascorbate, and free radicals: Combinations to avoid. Radiat Res 145(5):532-541.
6. Hovorka S, Schoneich C. 2001. Oxidative degradation of pharmaceuticals: Theory, mechanisms, and inhibition. J Pharm Sci 90(3):253-269.
7. Niki E. 1990. Free radical initiators as source of water- or lipid-soluble peroxyl radicals. Methods Enzymol 186:100-108.
8. Byrn SR, Sutton PA, Tobias B, Frye JPM. 1988. The crystal structure, solid-state NMR spectra, and oxygen reactivity of five crystal forms of prednisolone tert-butylacetate. J Am Chem Soc 110:5.
9. Clay RJ, Knevel AM, Byrn SR. 1982. The desolvation and oxidation of crystals of dialuric acid monohydrate. J Pharm Sci 71(11):1289-1291.
10. Beckwith AIJ, Eichinger PH, Mooney BA, Prager RH. 1983. Amine autoxidation in aqueous solution. Aust J Chem 36:20.
11. Block E. 1978. Reactions of organosulfur compounds. New York: Academic Press, p 16.
12. Bindra DS, Williams TD, Stella VJ. 1994. Degradation of O6-benzylguanine in aqueous polyethylene glycol 400 (PEG 400) solutions: Concerns with formaldehyde in PEG 400. Pharm Res 11(7):1060-1064.
13. Hartauer KJ, Arbuthnot GN, Baertschi SW, Johnson RA, Luke WD, Pearson NG, Rickard EC, Tingle CA, Tsang PK, Wiens RE. 2000. Influence of peroxide impurities in povidone and crospovidone on the stability of raloxifene hydrochloride in tablets: Identification and control of an oxidative degradation product. Pharm Dev Technol 5(3):303-310.
14. Johnson DM, Taylor WF. 1984. Degradation of fenprostalene in polyethylene glycol 400 solution. J Pharm Sci 73(10):1414-1417.
15. McGinity JW, Hill JA, La Via AL. 1975. Influence of peroxide impurities in polyethylene glycols on drug stability. J Pharm Sci 64(2):356-357.
16. Sellers R. 1980. Spectrophotometric determination of hydrogen peroxide using potassium titanium oxalate. Analyst 105:950-954.
17. Li HX, Ding MY, Lv K, Yu JY. 2002. Simultaneous separation and determination of ephedrine alkaloids and tetramethylpyrazine in ephedra sinica. J Liq Chromatogr Relat Technol 25(2):313-320.
18. Manatt SL, Manatt MR. 2004. On the analyses of mixture vapor pressure data: The hydrogen peroxide/water system and its excess thermodynamic functions. Chemistry 10(24):6540-6557.
19. Shekelle PG, Hardy ML, Morton SC, Maglione M. 2003. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance. JA MA 289(12):1537-1545.
20. Beckett AH, Jones GR, Hollingsbee DA. 1978. Degradation of ephedrine in solution and during extraction with diethyl ether. J Pharm Pharmacol 30:15-19.